Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStandard Chartered Regulatory News (STAN)

Share Price Information for Standard Chartered (STAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 755.00
Bid: 751.00
Ask: 751.20
Change: -1.00 (-0.13%)
Spread: 0.20 (0.027%)
Open: 756.00
High: 767.00
Low: 748.00
Prev. Close: 756.00
STAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19: dividend, buy-back & new commitments

1 Apr 2020 07:00

RNS Number : 3180I
Standard Chartered PLC
01 April 2020
 

STANDARD CHARTERED PLC

31 March 2020

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

COVID-19: dividend, buy-back and new commitments

Dividends and share buy-back

Standard Chartered PLC (the Group) announces that in response to a request from the Prudential Regulation Authority and as a consequence of the unprecedented challenges facing the world due to the COVID-19 pandemic, its board has decided after careful consideration to withdraw the recommendation to pay a final dividend for 2019 of 20 cents per ordinary share and to suspend the buy-back programme announced on 28 February 2020.

Furthermore, no interim dividend on ordinary shares will be accrued, recommended or paid in 2020. The board's recommendation regarding a final dividend in 2020 will take into account the financial performance of the Group for the full year and the medium-term outlook at that time.

The board fully recognises the importance of dividends to the Group's owners. However, suspending shareholder distributions at this time will allow the Group to maximise its support for individuals, businesses and the communities in which it operates whilst at the same time preserving strong capital ratios and investing to transform the business for the long term.

The Group is well capitalised with low leverage and high levels of loss-absorbing capacity. Its capital and liquidity metrics remain well above regulatory thresholds.

Charitable funding and increased financing

The Group has a commitment to be 'Here for good'. It has always stepped up to live to that promise in times of challenge and is doing so again now.

With immediate effect the Group is launching a $50 million global fund to provide assistance to those affected by COVID-19. The Group will immediately contribute $25 million, will match other contributions including those made by its employees and will make further contributions as needed to reach the total. All board and management team members will be making personal contributions to the fund.

The Group has already implemented several other initiatives to provide economic support to clients and protect their wellbeing and to support the Group's 84,000 employees around the world.

And yesterday the Group announced that it is committing up to $1 billion of financing, offered at preferential rates, for companies that are providing goods and services to help in the fight against COVID-19, as well as to support the efforts of those that are re-deploying production resources to help fight the pandemic.

Remuneration and trading performance update

The board has committed to ensure that decisions regarding 2020 remuneration, including executive remuneration, will be taken in the light of the Group's overall performance and the challenges faced by the Group's various stakeholders resulting from the spread of COVID-19.

The Group will provide an update on its performance in the year-to-date and more details regarding its response to the COVID-19 pandemic at its first quarter earnings announcement on 29 April 2020.

Further information

The decisions announced today relate to the Group's ordinary shares and not to any other Group instruments.

As at the end of 30 March 2020 the Group had through the buy-back programme announced on 28 February 2020 purchased 38 million ordinary shares of $0.50 each through J.P. Morgan Securities plc for consideration of $218 million, representing a volume-weighted average price per share of £4.77. The Group holds no shares in Treasury.

This announcement contains inside information for the purposes of article 7 of EU Regulation 596/2014. This announcement will also be available on the group's website at: https://www.sc.com/en/investors/stock-exchange-announcements/

Enquiries to:

Mark Stride, Head of Investor Relations +44 (0) 20 7885 8596

Julie Gibson, Head of Media Relations +44 (0) 20 7885 2434

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDKFLFXBXLXBBX
Date   Source Headline
2nd May 20242:25 pmRNSQ1 2024 Pillar 3 Disclosures
2nd May 20242:06 pmRNSPublication of Supplementary Prospectus
2nd May 20247:00 amRNS1st Quarter Results
1st May 20245:40 pmRNSTransaction in Own Shares
1st May 202412:20 pmRNSNotice of Redemption
1st May 202410:03 amRNSTotal Voting Rights
30th Apr 20245:36 pmRNSTransaction in Own Shares
29th Apr 20245:29 pmRNSTransaction in Own Shares
26th Apr 20245:30 pmRNSTransaction in Own Shares
26th Apr 202410:17 amRNSOverseas Regulatory Announcement
25th Apr 20245:50 pmRNSTransaction in Own Shares
24th Apr 20246:25 pmRNSPublication of a Prospectus
24th Apr 20245:19 pmRNSTransaction in Own Shares
23rd Apr 20245:50 pmRNSTransaction in Own Shares
22nd Apr 20245:40 pmRNSTransaction in Own Shares
19th Apr 20245:35 pmRNSTransaction in Own Shares
18th Apr 20245:35 pmRNSTransaction in Own Shares
17th Apr 20245:35 pmRNSTransaction in Own Shares
16th Apr 20245:35 pmRNSTransaction in Own Shares
15th Apr 20246:05 pmRNSTransaction in Own Shares
12th Apr 20244:54 pmRNSTransaction in Own Shares
12th Apr 20242:05 pmRNSNotice to ADR Holders of 6.409% Preference Shares
11th Apr 20245:45 pmRNSTransaction in Own Shares
10th Apr 20245:30 pmRNSTransaction in Own Shares
9th Apr 20246:05 pmRNSTransaction in Own Shares
8th Apr 20245:16 pmRNSTransaction in Own Shares
8th Apr 202411:32 amRNSNotice of AGM 2024 and Notice of Class Meeting
5th Apr 202410:30 amRNSOverseas Regulatory Announcement
4th Apr 20245:30 pmRNSTransaction in Own Shares
3rd Apr 20245:13 pmRNSTransaction in Own Shares
2nd Apr 20245:45 pmRNSTransaction in Own Shares
2nd Apr 202410:54 amRNSTotal Voting Rights
2nd Apr 20249:30 amRNSChanges to presentation of financial information
28th Mar 20246:00 pmRNSTransaction in Own Shares
27th Mar 20246:22 pmRNSNotice to ADR Holders of 6.409% Preference Shares
27th Mar 20245:39 pmRNSTransaction in Own Shares
26th Mar 20245:35 pmRNSTransaction in Own Shares
26th Mar 20244:36 pmRNSDirector/PDMR Shareholding
25th Mar 20245:43 pmRNSTransaction in Own Shares
22nd Mar 20245:35 pmRNSTransaction in Own Shares
21st Mar 20245:55 pmRNSTransaction in Own Shares
20th Mar 20245:30 pmRNSTransaction in Own Shares
20th Mar 20243:08 pmRNSDirector/PDMR Shareholding
19th Mar 20246:05 pmRNSTransaction in Own Shares
19th Mar 20245:45 pmRNSPublication of Final Terms
18th Mar 20245:51 pmRNSTransaction in Own Shares
15th Mar 20245:53 pmRNSTransaction in Own Shares
15th Mar 20244:45 pmRNSHolding(s) in Company
15th Mar 20244:30 pmRNSDirector/PDMR Shareholding
15th Mar 20243:35 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.